FDA is warning consumers not to purchase and immediately stop using EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears due to potential bacterial contamination.
OTI opened with a pilot program to provide services to patients as well as clinical experience to graduate students in the Department of Occupational Therapy. The pilot program was successful; however, we do not have the funding needed to move to the next stage.
The PCO Focal Point newsletter showcases interesting cases at TEI as well as our fabulous PCO students and stellar faculty.